{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T23:13:03Z","timestamp":1787008383234,"version":"build-2736575974"},"reference-count":23,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[2023,11,13]],"date-time":"2023-11-13T00:00:00Z","timestamp":1699833600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,1,17]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Aims<\/jats:title>\n                    <jats:p>To outline the demographic, clinical, laboratory characteristics, and treatment outcomes of tuberculosis (TB) patients who used substances.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This retrospective cohort study compared 50 TB patients who used substances with a matched random sample of 100 TB patients who did not use substances between 2007 and 2017. Treatment failure was defined as a sputum smear or culture that tested positive after 5\u00a0months of treatment, loss to follow-up, unevaluated patients, or death.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>TB patients who used substances were typically younger, experienced homelessness, smokers, and had fewer chronic diseases than those who did not use substances. They also were hospitalized for longer periods, their treatment durations were longer, had higher rates of multidrug resistant strains, increased rates of treatment failure, and higher mortality. Individuals whose treatment failed predominantly originated from the former Soviet Union, experienced homelessness, and had chronic diseases compared with those whose treatment was successful. In the multivariate analysis, homelessness [odds ratios (OR)\u2009=\u20096.7], chronic diseases (OR\u2009=\u200912.4), and substance use (OR\u2009=\u20094.0) were predictors of treatment failures.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>TB patients who used substances were more likely to have treatment failure. Targeted interventions, including early diagnosis and enhanced support during treatment, are essential to achieve treatment success in this vulnerable population, in addition to TB-alcohol\/drug collaborative activities.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/alcalc\/agad073","type":"journal-article","created":{"date-parts":[[2023,10,16]],"date-time":"2023-10-16T16:48:53Z","timestamp":1697474933000},"source":"Crossref","is-referenced-by-count":6,"title":["A retrospective cohort analysis of treatment outcomes of patients with tuberculosis who used substances in Tel Aviv, Israel"],"prefix":"10.1093","volume":"59","author":[{"given":"Ehud","family":"Kaliner","sequence":"first","affiliation":[{"name":"Central District Department of Health, Ministry of Health , Ramla , Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0383-146X","authenticated-orcid":false,"given":"Sandy","family":"Bornstein","sequence":"additional","affiliation":[{"name":"School of Medicine , Faculty of Medicine, , Tel Aviv , Israel"},{"name":"Tel Aviv University , Faculty of Medicine, , Tel Aviv , Israel"},{"name":"Tel Aviv Department of Health, Ministry of Health , Tel Aviv , Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Doaa","family":"Kabha","sequence":"additional","affiliation":[{"name":"School of Medicine , Faculty of Medicine, , Tel Aviv , Israel"},{"name":"Tel Aviv University , Faculty of Medicine, , Tel Aviv , Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moshe","family":"Lidji","sequence":"additional","affiliation":[{"name":"Tel Aviv Tuberculosis Clinic, Association Against Tuberculosis and Lung Diseases , Tel Aviv , Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rivka","family":"Sheffer","sequence":"additional","affiliation":[{"name":"Tel Aviv Department of Health, Ministry of Health , Tel Aviv , Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zohar","family":"Mor","sequence":"additional","affiliation":[{"name":"Central District Department of Health, Ministry of Health , Ramla , Israel"},{"name":"School of Medicine , Faculty of Medicine, , Tel Aviv , Israel"},{"name":"Tel Aviv University , Faculty of Medicine, , Tel Aviv , Israel"},{"name":"Department of Public Health, Ashkelon Academic College , Ashkelon , Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2023,11,13]]},"reference":[{"key":"2024011803333310300_ref1","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1186\/1471-2458-14-46","article-title":"The importance of providing counselling and financial support to patients receiving treatment for multi-drug resistant TB: mixed method qualitative and pilot intervention studies","volume":"14","author":"Baral","year":"2014","journal-title":"BMC Public Health"},{"key":"2024011803333310300_ref2","author":"Center for Disease Control and Prevention","year":"2023"},{"key":"2024011803333310300_ref3","volume-title":"The Tuberculosis Epidemic: Legal and Ethical Issues for Alcohol and Other Drug Treatment Providers","author":"Center for Substance Abuse Treatment","year":"1995"},{"key":"2024011803333310300_ref4","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/S0749-3797(00)00283-X","article-title":"Incentives vs outreach workers for latent tuberculosis treatment in drug users","volume":"20","author":"Malotte","year":"2001","journal-title":"Am J Prev Med"},{"key":"2024011803333310300_ref5","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.5588\/ijtld.16.0306","article-title":"Seasonality of tuberculosis in Israel, 2001\u20132011","volume":"20","author":"Margalit","year":"2016","journal-title":"Int J Tuberc Lung Dis"},{"key":"2024011803333310300_ref6","author":"Ministry of National Security, Israel","year":"2016"},{"key":"2024011803333310300_ref7","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.5588\/ijtld.14.0192","article-title":"Drug-resistant tuberculosis in Israel: risk factors and treatment outcomes","volume":"18","author":"Mor","year":"2014","journal-title":"Int J Tuberc Lung Dis"},{"key":"2024011803333310300_ref8","doi-asserted-by":"crossref","first-page":"954","DOI":"10.5588\/ijtld.12.0480","article-title":"Social, economic, and psychological impacts of MDR-TB treatment in Tijuana, Mexico: a patient\u2019s perspective","volume":"17","author":"Morris","year":"2013","journal-title":"Int J Tuberc Lung Dis"},{"key":"2024011803333310300_ref9","doi-asserted-by":"crossref","first-page":"444","DOI":"10.5588\/ijtld.22.0650","article-title":"Smoked drug use in patients with TB is associated with higher bacterial burden","volume":"27","author":"Myers","year":"2023","journal-title":"Int J Tuberc Lung Dis"},{"key":"2024011803333310300_ref10","first-page":"775","article-title":"A randomized controlled trial of two treatment programs for homeless adults with latent tuberculosis infection","volume":"10","author":"Nyamathi","year":"2006","journal-title":"Int J Tuberc Lung Dis"},{"key":"2024011803333310300_ref11","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1177\/0033354917694008","article-title":"Outbreak of drug-resistant mycobacterium tuberculosis among homeless people in Atlanta, Georgia, 2008\u20132015","volume":"132","author":"Powell","year":"2017","journal-title":"Public Health Rep"},{"key":"2024011803333310300_ref12","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1186\/1471-2458-9-450","article-title":"The association between alcohol use, alcohol use disorders and tuberculosis (TB). A systematic review","volume":"9","author":"Rehm","year":"2009","journal-title":"BMC Public Health"},{"key":"2024011803333310300_ref13","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1007\/s11481-011-9292-5","article-title":"Opioid drug abuse and modulation of immune function: consequences in the susceptibility to opportunistic infections","volume":"6","author":"Roy","year":"2011","journal-title":"J Neuroimmune Pharmacol"},{"key":"2024011803333310300_ref14","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijtb.2023.05.019","article-title":"Need for implementation of national framework for tuberculosis-alcohol (TB-alcohol) collaborative activities in India-drifting closer to TB elimination by 2025","author":"Rupani","year":"2023","journal-title":"Indian Journal of Tuberculosis"},{"key":"2024011803333310300_ref15","doi-asserted-by":"crossref","first-page":"687","DOI":"10.26719\/2013.19.8.687","article-title":"Factors associated with treatment default by tuberculosis patients in Fez, Morocco","volume":"19","author":"Slama","year":"2013","journal-title":"East Mediterr Health J"},{"key":"2024011803333310300_ref16","author":"Stop TB Partnership","year":"2016"},{"key":"2024011803333310300_ref17","author":"Stop TB Partnership","year":"2019"},{"key":"2024011803333310300_ref18","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0147397","article-title":"Psycho-socio-economic issues challenging multidrug resistant tuberculosis patients: a systematic review","volume":"11","author":"Thomas","year":"2016","journal-title":"PloS One"},{"key":"2024011803333310300_ref19","doi-asserted-by":"crossref","first-page":"S106","DOI":"10.1016\/S0924-977X(11)70114-6","article-title":"S.1.05 Psychopharmacological strategy in the treatment of drug dependence","volume":"21","author":"Vinnikova","year":"2011","journal-title":"Eur Neuropsychopharmacol"},{"key":"2024011803333310300_ref20","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.864817","article-title":"The impact of alcohol use disorder on tuberculosis: a review of the epidemiology and potential immunologic mechanisms","volume":"13","author":"Wigger","year":"2022","journal-title":"Front Immunol"},{"key":"2024011803333310300_ref21","author":"World Health Organization","year":"2020"},{"key":"2024011803333310300_ref22","author":"World Health Organization","year":"2022"},{"key":"2024011803333310300_ref23","author":"World Health Organization","year":"2022"}],"container-title":["Alcohol and Alcoholism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/alcalc\/article-pdf\/59\/2\/agad073\/56168147\/agad073.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/alcalc\/article-pdf\/59\/2\/agad073\/56168147\/agad073.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,17]],"date-time":"2024-01-17T22:33:53Z","timestamp":1705530833000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/alcalc\/article\/doi\/10.1093\/alcalc\/agad073\/7416983"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,13]]},"references-count":23,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024,1,17]]}},"URL":"https:\/\/doi.org\/10.1093\/alcalc\/agad073","relation":{},"ISSN":["0735-0414","1464-3502"],"issn-type":[{"value":"0735-0414","type":"print"},{"value":"1464-3502","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2024,3]]},"published":{"date-parts":[[2023,11,13]]},"article-number":"agad073"}}